State of Wyoming Increases Stake in Amrize Ltd $AMRZ

State of Wyoming boosted its position in shares of Amrize Ltd (NYSE:AMRZ) by 1,725.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 12,046 shares of the company’s stock after purchasing an additional 11,386 shares during the quarter. State of Wyoming’s holdings in Amrize were worth $651,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Basepoint Wealth LLC purchased a new stake in Amrize during the 4th quarter valued at about $33,000. Laurel Wealth Advisors LLC purchased a new stake in Amrize during the 4th quarter valued at about $34,000. US Bancorp DE purchased a new stake in Amrize during the 3rd quarter valued at about $38,000. Costello Asset Management INC purchased a new stake in Amrize during the 3rd quarter valued at about $44,000. Finally, Jones Financial Companies Lllp purchased a new stake in Amrize during the 3rd quarter valued at about $53,000.

Insider Transactions at Amrize

In other Amrize news, insider Mario Gross acquired 3,200 shares of the stock in a transaction dated Friday, March 13th. The shares were purchased at an average price of $55.29 per share, for a total transaction of $176,928.00. Following the purchase, the insider directly owned 30,947 shares of the company’s stock, valued at approximately $1,711,059.63. This trade represents a 11.53% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Jan Philipp Jenisch acquired 21,417 shares of the stock in a transaction dated Friday, May 15th. The stock was acquired at an average price of $49.67 per share, for a total transaction of $1,063,782.39. Following the purchase, the chief executive officer directly owned 1,724,999 shares in the company, valued at approximately $85,680,700.33. This trade represents a 1.26% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders have purchased 71,554 shares of company stock worth $3,669,069. 0.54% of the stock is currently owned by corporate insiders.

Amrize Price Performance

AMRZ opened at $53.49 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The stock has a market capitalization of $29.58 billion and a P/E ratio of 25.59. The company’s 50-day simple moving average is $54.36 and its two-hundred day simple moving average is $55.31. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $65.94.

Amrize (NYSE:AMRZ) last posted its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company’s revenue was up 4.7% on a year-over-year basis. As a group, analysts predict that Amrize Ltd will post 2.76 EPS for the current year.

Amrize Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is 21.05%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on AMRZ. Wall Street Zen raised shares of Amrize from a “sell” rating to a “hold” rating in a research report on Sunday, March 1st. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price on the stock in a research note on Friday, May 1st. Citigroup lowered their target price on shares of Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Royal Bank Of Canada lowered their target price on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. Finally, Truist Financial lowered their target price on shares of Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Amrize presently has an average rating of “Moderate Buy” and a consensus price target of $64.86.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.